International Stem Cell Corp
OTC:ISCO
International Stem Cell Corp
Research & Development
International Stem Cell Corp
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
International Stem Cell Corp
OTC:ISCO
|
Research & Development
-$746k
|
CAGR 3-Years
-8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
17%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Research & Development
-$9.1B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Research & Development
-$5.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Research & Development
-$7.2B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-6%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Research & Development
-$3.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-15%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Research & Development
-$5.2B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-12%
|
|
International Stem Cell Corp
Glance View
International Stem Cell Corp. operates as a clinical stage biotechnology company. The company is headquartered in Carlsbad, California. The company went IPO on 2006-09-25. The firm is focused on therapeutic and biomedical product development. The firm's segments include therapeutic market, anti-aging market and biomedical market. The firm is primarily a research and development company, for the therapeutic market, which is focused on clinical applications of human parthenogenetic stem cells (hpSCs) for the treatment of various diseases of the central nervous system and liver diseases. The firm's subsidiaries include Lifeline Cell Technology, LLC (LCT), which develops, manufactures and commercializes primary human cell research products for the biomedical market; Lifeline Skin Care, Inc. (LSC) that develops, manufactures and markets a category of anti-aging skin care products for anti-aging market, and Cyto Therapeutics Pty. Ltd. (Cyto Therapeutics) performs research and development (R&D) for the therapeutic market.
See Also
What is International Stem Cell Corp's Research & Development?
Research & Development
-746k
USD
Based on the financial report for Jun 30, 2025, International Stem Cell Corp's Research & Development amounts to -746k USD.
What is International Stem Cell Corp's Research & Development growth rate?
Research & Development CAGR 10Y
17%
Over the last year, the Research & Development growth was -28%. The average annual Research & Development growth rates for International Stem Cell Corp have been -8% over the past three years , 6% over the past five years , and 17% over the past ten years .
